ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
122.56 EUR
-3.74 (-2.96%)
We assign a fundamental rating of 6 out of 10 to ILU. ILU was compared to 22 industry peers in the Life Sciences Tools & Services industry. ILU gets an excellent profitability rating and is at the same time showing great financial health properties. ILU has a correct valuation and a medium growth rate. These ratings would make ILU suitable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year ILU was profitable.
- ILU had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
- In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ILU (11.38%) is better than 95.45% of its industry peers.
- The Return On Equity of ILU (29.53%) is better than 100.00% of its industry peers.
- ILU has a better Return On Invested Capital (14.61%) than 95.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of ILU (16.39%) is better than 86.36% of its industry peers.
- ILU's Operating Margin of 20.41% is amongst the best of the industry. ILU outperforms 86.36% of its industry peers.
- In the last couple of years the Operating Margin of ILU has declined.
- ILU has a better Gross Margin (66.74%) than 100.00% of its industry peers.
- ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
- ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, ILU has about the same amount of shares outstanding.
- Compared to 5 years ago, ILU has more shares outstanding
- ILU has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.61 indicates that ILU is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.61, ILU belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
- ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
- ILU has a Debt to FCF ratio of 1.99. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
- The Debt to Equity ratio of ILU (0.42) is better than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.61 |
ROIC/WACC1.37
WACC10.69%
2.3 Liquidity
- A Current Ratio of 1.43 indicates that ILU should not have too much problems paying its short term obligations.
- ILU has a Current ratio (1.43) which is in line with its industry peers.
- ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
- ILU has a better Quick ratio (1.12) than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
- Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
- ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
- Measured over the past years, ILU shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
- The Earnings Per Share is expected to grow by 24.95% on average over the next years. This is a very strong growth
- Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 3.99% on average per year.
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue Next Year-0.86%
Revenue Next 2Y0.68%
Revenue Next 3Y2.56%
Revenue Next 5Y3.99%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 32.77, which means the current valuation is very expensive for ILU.
- ILU's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.33, ILU is valued at the same level.
- A Price/Forward Earnings ratio of 27.86 indicates a quite expensive valuation of ILU.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU is on the same level as its industry peers.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, ILU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.77 | ||
| Fwd PE | 27.86 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
- 77.27% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.82 | ||
| EV/EBITDA | 19.4 |
4.3 Compensation for Growth
- ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ILU has a very decent profitability rating, which may justify a higher PE ratio.
- ILU's earnings are expected to grow with 34.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y44.64%
EPS Next 3Y34.05%
5. Dividend
5.1 Amount
- No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (1/14/2026, 7:00:00 PM)
122.56
-3.74 (-2.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap18.73B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts73.33
Price Target107.33 (-12.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)1.61%
PT rev (3m)9.76%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)3.08%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.77 | ||
| Fwd PE | 27.86 | ||
| P/S | 5.09 | ||
| P/FCF | 21.82 | ||
| P/OCF | 19.45 | ||
| P/B | 9.16 | ||
| P/tB | 20.92 | ||
| EV/EBITDA | 19.4 |
EPS(TTM)3.74
EY3.05%
EPS(NY)4.4
Fwd EY3.59%
FCF(TTM)5.62
FCFY4.58%
OCF(TTM)6.3
OCFY5.14%
SpS24.09
BVpS13.37
TBVpS5.86
PEG (NY)0.34
PEG (5Y)N/A
Graham Number33.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.61 |
F-Score7
WACC10.69%
ROIC/WACC1.37
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.95%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.86%
Revenue Next 2Y0.68%
Revenue Next 3Y2.56%
Revenue Next 5Y3.99%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year36.79%
EBIT Next 3Y17.14%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status for ILU stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for ILU stock?
The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.